Preclinical evaluation of the dual mTORC1/2 inhibitor sapanisertib in combination with cisplatin in nasopharyngeal carcinoma
Author:
Funder
Wu Jieping Medical Foundation
Publisher
Elsevier BV
Subject
Pharmacology
Reference27 articles.
1. The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions;Baghery Saghchy Khorasani;Eur. J. Pharmacol.,2021
2. mTOR inhibitor RAD001 (everolimus) induces apoptotic, not autophagic cell death, in human nasopharyngeal carcinoma cells;Cai;Int. J. Mol. Med.,2013
3. The evolving epidemiology of nasopharyngeal carcinoma;Chang;Cancer Epidemiol. Biomarkers Prev.,2021
4. Nasopharyngeal carcinoma;Chen;Lancet,2019
5. Drug combination studies and their synergy quantification using the Chou-Talalay method;Chou;Cancer Res.,2010
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Roles of mTOR Signaling in Nasopharyngeal Carcinoma: From Pathogenesis to Therapy;Current Molecular Pharmacology;2024-07-29
2. Combining Mefloquine with an Mcl-1 Inhibitor as a Novel Therapeutic Strategy for the Treatment of Nasopharyngeal Carcinoma;Nutrition and Cancer;2024-05-25
3. Molecular Diagnosis of Nasopharyngeal Carcinoma: Past and Future;Biomedical Journal;2024-05
4. Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells;Cells;2024-02-06
5. Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers;International Journal of Molecular Sciences;2024-02-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3